Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$43.48 USD
+1.01 (2.38%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $43.49 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.69 |
EPS Last Quarter | -0.69 |
Last EPS Surprise | 5.48% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.86 |
Next Year | -3.15 |
EPS (TTM) | -2.51 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.71M | 10.32M | 52.62M | 62.94M |
# of Estimates | 10 | 9 | 11 | 11 |
High Estimate | 28.50M | 15.00M | 125.00M | 129.10M |
Low Estimate | 4.90M | 5.00M | 15.20M | 14.40M |
Year ago Sales | 16.51M | 4.73M | 78.59M | 52.62M |
Year over Year Growth Est. | -29.07% | 118.22% | -33.05% | 19.62% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.69 | -0.74 | -2.86 | -3.15 |
# of Estimates | 12 | 10 | 13 | 13 |
Most Recent Consensus | -0.64 | -0.64 | -2.54 | -2.55 |
High Estimate | -0.41 | -0.64 | -1.92 | -2.00 |
Low Estimate | -0.81 | -0.84 | -3.71 | -4.24 |
Year ago EPS | -0.67 | -0.90 | -2.52 | -2.86 |
Year over Year Growth Est. | -2.99% | 17.78% | -13.49% | -10.01% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.69 | -0.74 | -2.86 | -3.15 |
7 Days Ago | -0.69 | -0.74 | -2.86 | -3.15 |
30 Days Ago | -0.69 | -0.74 | -2.86 | -3.15 |
60 Days Ago | -0.69 | -0.74 | -2.86 | -3.15 |
90 Days Ago | -0.75 | -0.81 | -3.15 | -3.44 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.69 | -0.74 | -2.86 | -3.15 |
Zacks Consensus Estimate | -0.69 | -0.74 | -2.86 | -3.15 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.69 | -0.25 | -0.90 | -0.67 | NA |
Estimate | -0.73 | -0.44 | -0.73 | -0.70 | NA |
Difference | 0.04 | 0.19 | -0.17 | 0.03 | 0.02 |
Surprise | 5.48% | 43.18% | -23.29% | 4.29% | 7.42% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more